Table of Contents
International Journal of Proteomics
Volume 2015, Article ID 587250, 10 pages
http://dx.doi.org/10.1155/2015/587250
Research Article

A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma

1Department of Immunotechnology and CREATE Health, Lund University, Medicon Village 406, 223 81 Lund, Sweden
2Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 28029 Madrid, Spain
3Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 28029 Madrid, Spain
4Department of Experimental and Health Sciences, University of Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain
5Hospital del Mar Medical Research Institute (IMIM), CIBERESP, UAB, Dr. Aiguader 88, 08003 Barcelona, Spain

Received 20 May 2015; Accepted 28 September 2015

Academic Editor: Djuro Josic

Copyright © 2015 Anna S. Gerdtsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Figure 1: Slide and microarray lay-out.

Supplementary Figure 2: Data visualized by principal component analysis.

Supplementary Figure 3: Biomarker assessment by database queries for diseases by biomarkers.

Supplementary Table 1: Antigens targeted on the antibody microarray.

Supplementary Table 2: Context-independent motif specific antibodies used on the antibody microarrays.

  1. Supplementary Material